<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04426617</url>
  </required_header>
  <id_info>
    <org_study_id>MS-258-2019</org_study_id>
    <nct_id>NCT04426617</nct_id>
  </id_info>
  <brief_title>Fentanyl Versus Midazolam As Additives To Bupivacaine In Ultrasound Guided Transversus Abdominis Plane Block</brief_title>
  <official_title>Comparison Between Fentanyl And Midazolam As Additives To Bupivacaine In Ultrasound Guided Transversus Abdominis Plane Block in Patients Undergoing Abdominal Surgeries; A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain triggers a complex biochemical and physiological stress response leading to impairment&#xD;
      of pulmonary, immunological and metabolic functions.&#xD;
&#xD;
      The Transversus Abdominis Plane (TAP) block, is a regional anaesthesia technique used for&#xD;
      various surgeries through the lower to mid-abdominal wall.The addition of fentanyl to the&#xD;
      local anaesthetic in ultrasound-guided TAP block prolongs the analgesia, lowers postoperative&#xD;
      pain, and decreases the opioid consumption. Adding midazolam as a bupivacaine adjuvant for&#xD;
      TAP block reduces the 24-h morphine consumption extends the postoperative analgesia duration.&#xD;
      The aim of the work is to study the effect of the addition fentanyl and midazolam on the&#xD;
      onset, duration of the analgesic effect of Tap block intraoperative fentanyl consumption,&#xD;
      Time for first rescue Analgesia.&#xD;
&#xD;
      in patients undergoing simple unilateral abdominal surgeries.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Informed written consent will be obtained from study participants or their legally authorized&#xD;
      representative. This is a randomized controlled double blinded study; patients will be&#xD;
      enrolled in the study and will be randomized and equally divided into three groups:&#xD;
&#xD;
      Group A: (TAP block with 20 ml of bupivacaine 0.25% and 50 μ g of fentanyl) Group B: (TAP&#xD;
      block with 20 ml bupivacaine 0.25% and 50 μ g /kg midazolam) Group C: (TAP block with 20 ml&#xD;
      bupivacaine 0.25% only). Induction of general anaesthesia will be performed using a regimen&#xD;
      of IV 1 μ g/kg fentanyl and Propofol IV 2 mg /kg. Tracheal intubation will be facilitated&#xD;
      using 0.5 mg/kg IV of atracurium.&#xD;
&#xD;
      Maintenance of Anaesthesia:&#xD;
&#xD;
      Anaesthesia will be maintained with inhaled sevoflurane with MAC 2% in oxygen enriched air&#xD;
      (FiO2=0.5) and top up doses of Atracurium (0.1 mg/kg) IV will be administered every 30&#xD;
      minutes.&#xD;
&#xD;
      Ringer acetate will be infused to replace their fluid deficit, maintenance and losses, and&#xD;
      the patients will be mechanically ventilated using the appropriate setting that will keep the&#xD;
      end-tidal CO2 at 30-35mmHg.&#xD;
&#xD;
      One reading of mean arterial pressure (MAP) and heart rate (HR) will be taken 1 minute before&#xD;
      induction of general anaesthesia (a baseline reading), 1 minute before surgical incision and&#xD;
      at 15-minute intervals intra operatively.&#xD;
&#xD;
      Lack of inadequate intraoperative analgesia, as defined by an increase in pulse rate,&#xD;
      sweating, and tearing (PRST) score &gt;2 or an increase of mean arterial blood pressure (MAP)&#xD;
      &gt;20% of baseline (8) was treated by additional rescue IV fentanyl 1-2 mcg/kg IV bolus.&#xD;
&#xD;
      Hypotension will be treated with 0.9% normal saline and/or 5mg ephedrine in incremental doses&#xD;
      to maintain mean blood pressure above 70 mmHg.&#xD;
&#xD;
      The residual neuromuscular blockade will be reversed using neostigmine (0.05 mg/kg) and&#xD;
      atropine (0.02 mg/kg), and extubation will be performed after complete recovery of the airway&#xD;
      reflexes.&#xD;
&#xD;
      The patient will be transferred to the post-anaesthesia care unit (PACU) where the MAP and HR&#xD;
      will be recorded immediately upon arrival.&#xD;
&#xD;
      Side effects such as local anaesthetic toxicity, postoperative nausea and vomiting (PONV),&#xD;
      respiratory depression (respiratory rate &lt;10/minute) will be recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 10, 2020</start_date>
  <completion_date type="Anticipated">July 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Onset of the Analgesic effect of TAP block with different additives</measure>
    <time_frame>30 minutes</time_frame>
    <description>The patient will be asked to register a prick respectively on the upper extremity. Sensory change will then be assessed in the mid-clavicular line, starting above dermatome T4 moving caudally to dermatome L4.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dose of intra-Operative fentanyl consumption</measure>
    <time_frame>2 hours</time_frame>
    <description>Lack of inadequate intraoperative analgesia, as defined by an increase in pulse rate, sweating, and tearing (PRST) score &gt;2 or an increase of mean arterial blood pressure (MAP) &gt;20% of baseline was treated by additional rescue IV fentanyl 1-2 mcg/kg IV bolus.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Block related complications</measure>
    <time_frame>24 hours</time_frame>
    <description>haematoma, neurological complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of first analgesic request</measure>
    <time_frame>24 hours</time_frame>
    <description>visual analogue scale equals or more than 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative nausea and vomiting</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>will be assessed using by yes/ no scale</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>fentanyle</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>: patients will receive US guided unilateral Transversus abdominis plane block (25 ml bupivacaine 0.25% &amp; fentanyl).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will receive us guided unilateral Transversus abdominis plane block (25 ml bupivacaine 0.25% &amp; midazolam).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patients will receive us guided unilateral Transversus abdominis plane block (25 ml bupivacaine 0.25%).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound Guided Transversus Abdominis Plane Block</intervention_name>
    <description>The patient will lie in the supine position. The transducer will be placed in the axial plane on the mid-axillary. transversus abdominis muscle will be visualized. A skin wheel using 3 ml of lidocaine 1 % is made 2 to 3 cm medial to the medial aspect of the transducer and the 22 gauge is inserted in-plane pointing laterally. Then Injection of local anaesthetic mixure in the right plane.</description>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>fentanyle</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Physical status ASA I and ASA ll.&#xD;
&#xD;
          -  Age ≥ 18 and ≤ 65 Years.&#xD;
&#xD;
          -  Body mass index (BMI): ≥ 20 kg/m2 and ≤ 35 kg/m2.&#xD;
&#xD;
          -  Patients undergoing Abdominal Surgeries.&#xD;
&#xD;
          -  Patient is able to provide a written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known sensitivity to local anaesthetics.&#xD;
&#xD;
          -  Significant liver or renal insufficiency.&#xD;
&#xD;
          -  Contraindication to regional anaesthesia e.g. local - sepsis, pre-existing peripheral&#xD;
             neuropathies and coagulopathy.&#xD;
&#xD;
          -  Patient refusal.&#xD;
&#xD;
          -  Failed Block.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>yahia hammad, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yahia Hammad</last_name>
    <phone>+201114048081</phone>
    <email>yahya196cm@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cairo university</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>yahia Hammad, M.D.</last_name>
      <phone>01224254012</phone>
      <email>bassantmohamed197@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Shereen Moustafa, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yahia Hammad, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Nehra P, Oza V, Parmar V, Fumakiya P. Effect of Addition of Fentanyl and Clonidine to Local Anesthetic Solution in Peribulbar Block. J Pharmacol Pharmacother. 2017 Jan-Mar;8(1):3-7. doi: 10.4103/jpp.JPP_109_16.</citation>
    <PMID>28405129</PMID>
  </reference>
  <reference>
    <citation>Carney J, Finnerty O, Rauf J, Bergin D, Laffey JG, Mc Donnell JG. Studies on the spread of local anaesthetic solution in transversus abdominis plane blocks. Anaesthesia. 2011 Nov;66(11):1023-30. doi: 10.1111/j.1365-2044.2011.06855.x. Epub 2011 Aug 18.</citation>
    <PMID>21851346</PMID>
  </reference>
  <results_reference>
    <citation>Tsai HC, Yoshida T, Chuang TY, Yang SF, Chang CC, Yao HY, Tai YT, Lin JA, Chen KY. Transversus Abdominis Plane Block: An Updated Review of Anatomy and Techniques. Biomed Res Int. 2017;2017:8284363. doi: 10.1155/2017/8284363. Epub 2017 Oct 31. Review.</citation>
    <PMID>29226150</PMID>
  </results_reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 8, 2020</study_first_submitted>
  <study_first_submitted_qc>June 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2020</study_first_posted>
  <last_update_submitted>June 10, 2020</last_update_submitted>
  <last_update_submitted_qc>June 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Bassant M. Abdelhamid</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

